Researchers have developed the first therapy for osteoarthritis that, in tests with mice, reverses the disease and regenerates cartilage and bone in weeks.

https://medicalxpress.com/news/2026-04-simple-shot-reverse-osteoarthritis-weeks.html

#Science #Health #Osteoarthritis #Arthritis

A simple shot shows promise to reverse osteoarthritis within weeks

A research team including scientists and engineers from University of Colorado Boulder, CU Anschutz and Colorado State University has developed a suite of new therapies that prompt aging or damaged joints to repair themselves within weeks, according to animal studies.

Medical Xpress
“inhibition of 15-PGDH—an enzyme that drives tissue aging, a “gerozyme”—leads to cartilage regeneration in aged mouse OA joints, in joints of young adult mice with posttraumatic OA (PTOA) resulting from an ACL tear” #osteoarthritis https://www.science.org/doi/10.1126/science.adx6649

🦴 Could a naturally occurring “biological lubricant” redefine how we treat joint health and gout?

🔗 Lubricin’s Mucin Domain Has Strong Polyproline Type II Helical Character. Computational and Structural Biotechnology Journal (CSBJ). DOI: https://doi.org/10.34133/csbj.0021

📚 CSBJ - A Science Partner Journal: https://spj.science.org/journal/csbj

#StructuralBiology #ProteinScience #Biophysics #ComputationalBiology #Osteoarthritis #Glycoproteins #MolecularBiology

A daily dietary supplement of inulin, a natural prebiotic fiber, significantly reduces joint pain, lowers pain sensitivity, and improves grip strength in patients diagnosed with knee #osteoarthritis
#Rheumatology #Gastroenterology #NutritionalScience #sflorg
https://www.sflorg.com/2026/03/nut03122601.html
Gut health supplement relieves arthritis pain, finds new study

A new study has found that a prebiotic fiber supplement reduced pain, improved grip strength

Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests

Medical researchers have discovered that semaglutide may reverse the debilitating tissue damage caused by osteoarthritis, the world's most common form of arthritis.

ScienceAlert

Synartro Reports LPLV in Phase I/IIa Study

Synartro announces the last participant's last visit in the Phase I/IIa clinical trial of SYN321, an intra-articular treatment for knee osteoarthritis. Initiated in August 2025, the study involved 35 participants across four cohorts to evaluate safety, tolerability, PK, and early efficacy.

#Synartro #Osteoarthritis #Biotech #ClinicalTrials

🚶‍♀️‍➡️ #Osteoarthritis affects over 500 million people globally, causing pain, stiffness and disability. Efforts to develop treatments are hampered by a range of factors.
💡 Enter IHI PROBE, a new project that aims to use a big data approach, powered by cutting-edge artificial intelligence (AI) and machine learning (ML), to advance the care of people living with knee osteoarthritis.
Find out more about the project 👉 https://link.europa.eu/3KnMRm
#HorizonEU #health #research
Scientists Found a Way to Regrow Cartilage Without Using Stem Cells

Scientists reversed joint damage in mice by reprogramming aging cartilage cells.

ZME Science